Underwriters for the offering included JPMorgan, Bank of America Merrill Lynch, Wells Fargo Securities and Canaccord Genuity. The underwriters were granted a 30-day option to purchase an additional 600,000 shares.
This IPO represents about 13.4% of Penumbra’s outstanding shares and places a market cap on the company of about $895 million, with an outstanding share count of 29.8 million. Gross proceeds of the IPO totaled $120 million, not including the underwriter’s option.
The company said in its Form S-1 filings that it currently has no specific plans for using the net proceeds, but it intends to use the proceeds for product development, including research and development and clinical trials; expansion of the sales force; working capital; and general corporate purposes.
Penumbra’s largest shareholder prior to this IPO was FMR, the investment management division of Fidelity Investments, with a stake of 11.6%, and company directors and executives owned another 24.8%. Neither group sold or bought shares in the IPO, and the two groups now own about 21.7% of outstanding shares. Penumbra said it had a total of 346 shareholders prior to this IPO.
Before noon on Friday, shares traded at $41.40, up 38%. The stock hit a high of $42 earlier in the morning.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.